Short-term administration of a combination of recombinant growth hormone and insulin-like growth factor-I induces anabolism in maintenance hemodialysis

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2299-2305

  Guebre Egziabher, Fitsum ^a,b,c   Juillard, Laurent ^a,b   Boirie, Yves ^d   Laville, Martine ^c   Beaufrère, Bernard ^d   Fouque, Denis ^a,b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Centre de Recherche en Nutrition Humaine de Lyon   (France)

^d CRNH AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ESSENTIAL AMINO ACID; INSULIN; LEUCINE; NONESSENTIAL AMINO ACID; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATREM;

ADULT; AMINO ACID BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DOSE KIDNEY FUNCTION RELATION; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HORMONE METABOLISM; HUMAN; IMMUNORADIOMETRIC ASSAY; INSULIN BLOOD LEVEL; MAINTENANCE THERAPY; MALE; OXIDATION; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS;

EID: 67650242220     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2262     Document Type: Article

References (31)

1. Kopple JD 1997 Uses and limitations of growth factors in renal failure. Perit Dial Int 17(Suppl 3):S63-S66
2. Ikizler TA, Wingard RL, Hakim RM 1995 Interventions to treat malnutrition in dialysis patients: the role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone. Am J Kidney Dis 26:256-265
3. Bellizzi V, Di Iorio BR, Terracciano V, Minutolo R, Iodice C, De Nicola L, Conte G 2003 Daily nutrient intake represents a modifiable determinant of nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant 18:1874-1881
4. Tonshoff B, Blum WF, Mehls O 1997 Derangements of the somatotropic hormone axis in chronic renal failure. Kidney Int Suppl 58:S106-S113
5. Kopple JD, Brunori G, Leiserowitz M, Fouque D 2005 Growth hormone induces anabolism in malnourished maintenance haemodialysis patients. Nephrol Dial Transplant 20:952-958
6. Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls O 1991 Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia. Pediatr Nephrol 5:539-544
7. Pupim LB, Flakoll PJ, Yu C, Ikizler TA 2005 Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients. Am J Clin Nutr 82:1235-1243
8. Ding H, Gao XL, Hirschberg R, Vadgama JV, Kopple JD 1996 Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. J Clin Invest 97:1064-1075
9. Fouque D, Peng SC, Kopple JD 1995 Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 47:876-883
10. Ding H, Qing DP, Kopple JD 1997 IGF-I resistance in chronic renal failure: current evidence and possible mechanisms. Kidney Int Suppl 62:S45-S47
11. Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R 2001 Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 108:467-475
12. Santos F, Chan JC, Hanna JD, Niimi K, Krieg Jr RJ, Wellons MD 1992 The effect of growth hormone on the growth failure of chronic renal failure. Pediatr Nephrol 6:262-266
13. Iglesias P, Diez JJ, Fernandez-Reyes MJ, Mendez J, Bajo MA, Aguilera A, Selgas R 2004 Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Clin Endocrinol (Oxf) 60:741-749
14. Horber FF, Haymond MW 1990 Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 86:265-272
15. Jacob R, Barrett E, Plewe G, Fagin KD, Sherwin RS 1989 Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest 83:1717-1723
16. Durnin JV, Womersley J 1974 Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97
17. Fouque D, Le Bouc Y, Laville M, Combarnous F, Joly MO, Raton P, Zech P 1995 Insulin-like growth factor-1 and its binding proteins during a low-protein diet in chronic renal failure. J Am Soc Nephrol 6:1427-1433
18. Boirie Y, Gachon P, Beaufrere B 1997 Splanchnic and whole-body leucine kinetics in young and elderly men. Am J Clin Nutr 65:489-495
19. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR 1993 Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 91:391-396
20. Carroll PV, Jackson NC, Russell-Jones DL, Treacher DF, Sonksen PH, Umpleby AM 2004 Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness. Am J Physiol Endocrinol Metab 286:E151-E157
21. Garibotto G, Barreca A, Russo R, Sofia A, Araghi P, Cesarone A, Malaspina M, Fiorini F, Minuto F, Tizianello A 1997 Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 99:97-105
22. Ike JO, Fervenza FC, Hoffman AR, Yeh I, Hintz RL, Liu F, Rabkin R 1997 Early experience with extended use of insulin-like growth factor-1 in advanced chronic renal failure. Kidney Int 51:840-849
23. Zdanowicz MM, Teichberg S 2003 Effects of insulin-like growth factor-1/binding protein-3 complex on muscle atrophy in rats. Exp Biol Med (Maywood) 228:891-897
24. Lang CH, Frost RA, Svanberg E, Vary TC 2004 IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats. Am J Physiol Endocrinol Metab 286:E916-E926
25. Bohe J, Low A, Wolfe RR, Rennie MJ 2003 Human muscle protein synthesis is modulated by extracellular, not intramuscular amino acid availability: a dose-response study. J Physiol 552:315-324
26. Bohe J, Rennie MJ 2006 Muscle protein metabolism during hemodialysis. J Ren Nutr 16:3-16
27. Baxter RC 2000 Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967-E976
28. Fouque D, Tayek JA, Kopple JD 1995 Altered mental function during intravenous infusion of recombinant human insulin-like growth factor 1. JPEN J Parenter Enteral Nutr 19:231-233
29. Fouque D, Peng SC, Shamir E, Kopple JD 2000 Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 57:646-654
30. Trepp R, Fluck M, Stettler C, Boesch C, Ith M, Kreis R, Hoppeler H, Howald H, Schmid JP, Diem P, Christ ER 2008 Effect of GH on human skeletal muscle lipid metabolism in GH deficiency. Am J Physiol Endocrinol Metab 294:E1127-E1134
31. Feldt-Rasmussen B, Lange M, Sulowicz W, Gafter U, Lai KN, Wiedemann J, Christiansen JS, El Nahas M 2007 Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. J Am Soc Nephrol 18:2161-2171